Oral oncolytics offer a host of benefits for both patients and providers, but cancer programs need to be equipped to properly manage and monitor patients who are self-administering their treatments at home.
Sponsored by Pfizer Oncology.
Read the white paper, Steps to Success: Implementing Oral Oncolytics from ACCC Member Programs, for effective practices, peer-to-peer insight, tools, and resources.
